insulet corp (PODD:NASDAQ GS)
Robert S. Sherwin M.D.
Chairman of Scientific Advisory Board, Insulet Corporation
|Age||Total Calculated Compensation||This person is connected to 44 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Mr. Robert S. Sherwin, MD is the CNH Long Professor of Medicine, Section of Endocrinology at Yale University School of Medicine. Mr. Sherwin also serves as Director of the Diabetes Endocrinology Research Center and the General Clinical Research Center, Yale University, New Haven, Connecticut. He was subsequently appointed to the faculty of Yale University School of Medicine in 1974. Mr. Sherwin serves as Chairman & Member of the Scientific Advisory Board of Insulet Corporation. ...
600 Technology Park DrivePhone: 978-600-7000
Billerica, Massachusetts 01821
Board Members Memberships*There is no Board Members Memberships data available.
Unknown/Other Education 1967
Albert Einstein College of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Kevin R. Sayer||Chief Executive Officer, President and Director|
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Philip Bowman||Chief Executive Officer and Executive Director|
Smiths Group plc
|Christophe Weber||Chief Executive Officer, President and Representative Director|
Takeda Pharmaceutical Company Limited
|Kim D. Blickenstaff||Chief Executive Officer, President and Director|
Tandem Diabetes Care, Inc.
|$532.7K||Compensation as of Fiscal Year 2014.|